Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells

Anticancer Res. 2011 Jun;31(6):2141-8.

Abstract

Aim: To assess radiosensitzing potential of huachansu (HCS) and delineate the underlying mechanisms.

Materials and methods: Lung cancer cell lines were exposed to HCS, radiation or both and subjected to survival assays, Western blots, apoptosis assay and immunocytochemical analysis.

Results: HCS suppressed the viability of all three lung lines tested and enhanced radiosensitivity of H460 and A549 (wild-type p53) only with no effect on H1299 (p53 null) cells. HCS prolonged the presence of radiation-induced γH2AX foci and increased radiation-induced apoptosis. Western blots showed that HCS increased cleaved caspase-3 and cleaved poly-(ADP-ribose) polymerase (PARP) levels, as well as reducing BCL-2 and p53 protein levels in H460 cells.

Conclusion: HCS-enhanced radiosensitivity of human lung cancer lines appeared to be p53-dependent. Inhibition of DNA repair and increase in radiation-induced apoptosis may have served as underlying mechanisms. These data suggest that HCS may have potential to improve the efficacy of radiotherapy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amphibian Venoms / chemistry
  • Amphibian Venoms / pharmacology*
  • Cardiac Glycosides / chemistry
  • Cardiac Glycosides / pharmacology
  • Cell Line, Tumor
  • Combined Modality Therapy
  • DNA Damage
  • DNA, Neoplasm / radiation effects
  • Dose-Response Relationship, Drug
  • Histones / biosynthesis
  • Histones / genetics
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / radiotherapy*
  • Radiation-Sensitizing Agents / pharmacology*

Substances

  • Amphibian Venoms
  • Cardiac Glycosides
  • DNA, Neoplasm
  • H2AX protein, human
  • Histones
  • Radiation-Sensitizing Agents
  • huachansu